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maximum and amounted up to 300 % control reaction, then 
decreased. First, with respect to in vitro research isolated 
by LITA rings, while analyzing the results of the research, 
one should take into consideration the possibility that dur-
ing the research, the functional state of the tissues changes 
and in particular its sensitivity to depolarization of the cell 
membrane. Second, the change in the sensitivity to depolar-
ization of the cell membrane of the smooth muscles’ LITA 
might be the potential mechanism causing the occurrence 
of the postoperative spasm after the CABG treatment.
Keywords Bypass · Contractility · Depolarization · 
Potassium · Vasospasm
Introduction
Isolated blood vessel pharmacology allows the exploration 
of mechanisms of drug action, and establishment of con-
centration–response relationships for analysis of potency 
and range more readily than is possible in in vivo experi-
ments. It cannot identify the cause of in vivo vasoconstric-
tion; however, isolated tissue assays can determine what 
factors have the potential to contract the vessel in vivo. 
The left internal thoracic artery (LITA) is a dynamic con-
duit used for myocardial revascularization [1–4] in which 
potential exists as well for spasm as for vasodilatation. 
There are many vasoactive agents used in pharmacologic 
and surgical treatment of coronary artery disease which 
may influence the reactivity of LITA. Some of them are 
described as having long-lasting effects [5–7].
Studies of LITA reactivity reported in the literature are 
based on in vitro measurements after 30–90 min incuba-
tion [6, 8–12]. There is a lack of information about the pos-
sible influence of preoperative pharmacology, especially 
Abstract The aim of the present study was to examine 
how, under in vitro conditions, the human left internal tho-
racic artery (LITA) reacts to contractile agonist:potassium 
chloride (KCL) as a function of time, as well as to exam-
ine whether a change in the LITA reactivity can corre-
late with the occurrence of the refractory vascular spasm 
(RVS). Distal segments of LITA obtained from 33 patients 
aged 38–73, at the time of routine coronary artery surgi-
cal revascularization (CABG). Contractile response to 
80 mmol K+ was recorded under isometric conditions. In 
16 (48,5 %) LITA segments, contractile reaction to K+ 
after experiments ranging 1–10 h were registered. No con-
tractile response even after 10 h of incubation was observed 
in 17 (51.5 %) LITA segments. Between 120 and 300 min 
after the beginning of the experiment, the reaction was 
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long-acting vasodilators, on the incubation time needed to 
obtain vasoreactivity measurements. Our long-term expe-
rience in working on the LITA reactivity under in vitro 
conditions indicates that there are difficulties in obtain-
ing a contractile response using different factors causing 
contractions even during prolonged experiments. Likely, 
most experimenters will exclude vessels that do not react 
because they take for granted that they were damaged dur-
ing harvesting or during the experimental preparation. But 
is this assumption always correct? Our doubts emerged 
after preliminary trials in which the contraction induced by 
potassium and norepinephrine occurred even after several 
hours of incubation.
On the other hand, coronary artery spasm is a known 
complication of coronary artery bypass grafting (CABG) 
and can be associated with circulatory collapse and death. 
Refractory vascular spasm (RVS) has been reported to 
occur between 0.8 and 1.3 % of CABG procedures [13, 
14], although transient coronary or graft spasm has been 
shown to affect up to 11 % of operated patients [15]. Anal-
ysis of data from two multicenter prospective studies in 
Italy showed, that thirty-day postoperative mortality rate 
among octogenarians was at 6.5 % (147/2246 patients), 
which was significantly higher than among patients aged 
under 80 years [16]. However, the incidence and mortality 
rates may be underestimated because mainly the surviving 
cases are reported and exact diagnosis can only be achieved 
with coronary angiography. In the cases described in the 
literature, confirmed by the angiographic research, the 
RVS occurred between 2 and 8 h after the surgery [17–21]. 
Thus, it seems that the greatest risk of postoperative cor-
onary artery spasm is very early after CABG surgery and 
that this risk declines with time.
We have decided to verify how the LITA reactivity 
changes as a function of time during long-hour incubation 
to see what effect might it have on the results of in vitro 
research lead using standard procedures and whether a 
change in LITA reactivity might correlate with the occur-
rence of RVS in patients subjected to CABG.
Materials and methods
Distal segments of LITA obtained from 33 non-diabetic 
patients aged 38–73, at the time of routine coronary artery 
surgical revascularization. This study was reviewed and 
approved by the local committee of the ethics on human 
research (the approval reference number–R-I-003/42/2002). 
Because the internal thoracic artery obtained during coro-
nary artery bypass operation was classified as a surgical 
specimen, its use was exempted by the committee from 
required patient consent. The study was performed con-
form the declaration of Helsinki.
Patients were preoperatively long-term treated with:
1. Beta-blockers—administered just prior to surgery
–– Selective (bisoprolol—half-life 17 ± 5 h),
–– Non-selective (metoprolol—half-life 3.5 h);
2. ACE-inhibitor—discontinued at least 12 h prior to sur-
gery—ramipril—The maximum effect after the admin-
istration of a single oral dose occurs normally within 
3–6 h;
3. Calcium channel blocker—discontinued at least 12 h 
prior to surgery—amlodipine—half-life 35–50 h;
4. Nitrates—administered just prior to surgery—half-life 
4–5 h.
5. Statins—discontinued at least 24 h prior to surgery—
simvastatin, atorvastatin
After removal, the tissue was treated with papaverine for 
a period of 5–30 min.
Any obtained segments were collected and put into 
container with oxygenated physiologic solution main-
tained at 4° C (NaCl-121, KCl-4.7, NaHCO3-24.7, 
MgSO4-12.2, CaCl2-2.5, KH2PO4-1.2, glucose-5.8, 
(mmol/L)), pH 7.4, and then transferred to a laboratory 
immediately.
Under a dissecting microscope, arterial rings (length 
2–3 mm) were prepared. The rings were mounted in an 
organ bath containing the physiological salt solution of pH 
7,4 and at temperature 37 °C, and bubbled with carbogen 
(95 % O2 and 5 % CO2). The details of the technique were 
published previously [8, 11, 22, 23]. The experiment was 
started within 1–3 h of tissue recovery. At the beginning 
of the experiments, the rings were stretched to an initial 
tension of about 15 mN and allowed to relax and equili-
brate for about 1 h in the bathing medium then the vascu-
lar preparations were challenged once with norepinephrine 
(1 µM). If there was a reaction to norepinephrine, when 
the effect was levelling off, the presence of functional 
endothelial cells was tested by adding 1 µM acetylcholine. 
Then, the tissues were rinsed and after 1 h, K+ was admin-
istered (80 mmol). In case of tissues in which there was 
a reaction to norepinephrine, the administration of potas-
sium was repeated 6 times in 1-h intervals. In case the 
reaction to norepinephrine did not occur, the administra-
tion of potassium was repeated 10 times in 1-h intervals. 
Contractile response of the arterial rings was recorded 
under isometric conditions over 10 min. Quantification of 
the response was done by calculation of the area under the 
curve of contractions.
Statistical analysis
The data were reported as mean ± SEM. Data were evalu-
ated for statistical significance using two-way ANOVA 
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for repeated measures. A probability of less than 0.05 
(p < 0.05) was considered statistically significant.
Results
In 16 (48.5 %) LITA segments from 33 in the study group, 
contractile reaction to K+ after experiments ranging 1–10 h 
was registered. No contractile response even after 10 h of 
incubation was observed in 17 (51.5 %) LITA segments. 
Among 16 reacting tissues, only in 7 cases was there a 
reaction to norepinephrine and then to K+. In all those 7 
cases, the reaction to acetylcholine indicated the correct 
endothelium function. In other 9 cases, the reaction to 
potassium occurred at different times from the beginning 
of the experiment. Figure 1 shows the number of tissues in 
which there was a reaction to potassium in function of the 
period of incubation.
Unlike the data commonly presented in the literature 
[8, 9, 11, 24–26], we noticed that contractile reaction of 
investigated LITA segments may occur even after pro-
longed incubation time. In our series, 56.25 % of reacting 
tissues showed the response after incubating for longer 
than 120 min. From the whole study group, no contractile 
response even after 10 h of incubation was observed in 17 
(51.5 %) arteries.
In the case of 7 tissues in which there was a reaction 
to norepinephrine, the reaction to potassium was time-
dependent, as Fig. 1 shows.
In the period between 120 and 300 min after the begin-
ning of the experiment, the response to potassium was max-
imal and accounted for approximately 300 % of the control 
reaction, then decreased. Analysis of variance showed that 
the reactions after 120, 180, 240 and 300 min did not dif-
fered statistically significantly.
Discussion
In in vitro LITA rings tests usually standard procedures 
are used—different contractile agents or vasodilators or 
their combinations are analyzed. Tissues used in this kind 
of experiment are always taken from patients subject 
to long-term pharmacotherapy; usually the patients are 
administered with beta-blockers, calcium channel blockers, 
nitrates, ACE-inhibitors and the experiment is conducted as 
soon as possible after the removal of the tissue. The ques-
tion arises: how much does the tissue change during the in 
vitro experiment that takes up to a few hours and can one 
assume that during the whole experiment the tissues does 
not change its functional state? Only 21 % of the tested tis-
sues, taken from different patients in our experiment have 
responded with a contraction to NE and then KCl admin-
istration when the incubation time was shorter than 120 
min, and as much as 51.5 % of the tissues have not reacted 
with a contraction even after 10 h of incubation. In papers 
describing LIMA rings in vitro research, the authors usu-
ally quote the time of incubation between 30 and 90 min 
[6, 8–12]. We have not found in accessible literature any 
data describing experiments in which the LITA rings did 
not react with a contraction to NE and KC1 administra-
tion. So, either all tissues tested in different laboratories 
did react with a contraction to α-adrenoceptors stimulation 
and depolarization of the cell membrane (which in view of 
our long-term research on this tissue does seem unlikely) or 
only reacting tissues entered in the experiments and analy-
sis. The abolition of the contractile response to norepineph-
rine within a few hours from the collection of LITA may be 
caused by pre-incubation of the tissue with α-adrenoceptors 
inhibitor papaverine. Harrison and associates demonstrated 
that the protective effects of papaverine are relatively 
short-lived, when the human radial artery is challenged 
Fig. 1  The number of reacting 
tissues in relation to the period 
of incubation
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with NE. However, this complete inhibition of constric-
tion remained for 2 h after wash-out of papaverine and to 
4 h after pre-treatment with papaverine, the contraction is 
10−5 M NE was 21 ± 9 % of control vessels [27]. On the 
other hand, Mirkami and associates showed that papaver-
ine completely relaxed NE-induced contraction of the ITA 
[28]. Time elapsed in our experiments since the removal 
of the tissue to the first administration of the NE contained 
within 2–5 h. So it seems that the lack of response to NE, 
LITA for our experiments (79 %) can be explained by the 
inhibitory effect of papaverine. The contractile response 
to KCl require in intracellular calcium which is produced 
in response to membrane depolarization and extracellu-
lar Ca2+ influx through voltage-operated Ca2+ channels 
(VOC) triggers Ca2+—induced Ca2+ release from intracel-
lular stores [29–31]. The lack of reaction to KC1 adminis-
tration can thus indicate that this way of tissue stimulation 
is inactive and voltage-operated Ca2+ channels (VOC) may 
be blocked. With the passage of time of the experiment, the 
tissues start reacting to cell membrane depolarization with 
a contraction (Fig. 1). Such a situation, in our opinion, is 
caused, above all, by preoperative pharmacotherapy and, 
in particular, by long-acting blockers of the voltage-oper-
ated Ca2+ channels (VOC)—amlodipine administration. 
In their work, Bai and associates have shown that [32] the 
pretreatment of isolated LITA with plasma concentrations 
of amlodipine (−6.6 log M) significantly depressed subse-
quent contraction to KCl. During the in vitro experiment, 
when the tissue is repeatedly rinsed, a part of the channel 
does get unblocked and the tissue obtains the ability to 
contract. Another factor that may affect the functioning of 
the cell membrane of smooth muscle cells and VOCs may 
be the statins administered to the patients in the preopera-
tive period. There are many reports confirming synergistic 
effects of statins and calcium channel blockers [33–36]. At 
the same time, epidemiological studies have shown, that 
statin in combination with β-blocker therapy reduces post-
operative stroke after CABG [37], statins reduce short- and 
long-term mortality associated with postoperative atrial 
fibrillation after CABG [38], statin therapy was associ-
ated with reduced all-cause mortality among patients with 
chronic kidney disease (CKD) and coronary artery disease 
(CAD) after percutaneous coronary intervention (PCI) [38].
For the tissues, which did not react to KC1 administra-
tion in an incubation time shorter than 120 min, we have 
concluded that the reaction is time-dependent and at its 
maximum between 120 and 300 min after the beginning of 
the experiment (Fig. 2). Such a conclusion is suggested by 
the increase in calcium level inside the muscle cells during 
the experiment. It may be caused by the increased inflow 
of calcium from the intercellular space through the voltage-
operated Ca2+ channels (VOC) as well as by the release of 
a greater amount of calcium from intracellular stores. In 
our opinion, this effect may have an influence on the results 
of the in vitro experiments in which the influence of vari-
ous contractile agents or vasodilators, or their combination 
in LITA rings is analyzed and thus, such an effect should be 
included during the analysis of the obtained results of such 
research.
The research on isolated tissues may not include all the 
factors influencing the contractile LITA action in vivo, and 
in particular, the factors that cause the spasm. In this paper, 
we concentrated solely on the contraction caused by the 
depolarization of the cell membrane of the muscle cell.
Fig. 2  Reaction dependence on 
K+ (80 mmol) of 7 LITA rings. 
The control was the area under 
the curve for the first contrac-
tion of potassium for each 
tissue, respectively. Points rep-
resent mean values from n = 7 
individual experiments; vertical 
lines represent ± s.e. mean
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The spasm cases described in the literature do occur—
during the surgery at the operating room, during the trans-
port of the patient to the recovery room or within a short 
period of time (2–8 h) after the CABG surgery [17–21, 
39].
The time of the CABG surgery is naturally diversi-
fied and dependent on many factors. From the removal of 
LITA until chest closure about 60–180 min elapse. In our 
experiments, the time needed to move the tissue from the 
operation room to the laboratory, the tissue preparation, 
the placement of LITA rings in the incubation vessels and 
obtaining a stable basic voltage, is comparable with the 
time of a standard CABG surgery. We have not found in the 
accessible literature any detailed analysis of the time of the 
respective stages of the in vitro procedure in such research, 
however, on can assume, that it is similar to other laborato-
ries. Thus, if the first administration of the vessel contrac-
tile agent may be considered as the launch of the experi-
ment, the time is similar to the termination of the CABG 
surgery.
Seven out of 33 LITA rings have reacted with a contrac-
tion to KC1 administration at the beginning of the experi-
ment, thus in a time nearing the termination of the CABG 
surgery. In successive 2 h time intervals of the incubation, 
the number of tissues in which there was a contractile reac-
tion to KC1 administration was, respectively: 2, 4, 1 and 2. 
Of course this cannot be the basis for the conclusion that 
there is a correlation between the reaction time of the iso-
lated LITA rings caused by the KC1 and the possibility of 
spasm or other cardiovascular incidents occurrence among 
patients after the CABG surgery. Nevertheless, in our opin-
ion, this observation indicates that during in vitro studies of 
the ITA rings, the duration of each phase of the experiment, 
calculated since harvesting of the tissue is an important 
parameter that should be taken into account in the analysis 
of the results. This in-depth analysis would help to translate 
the received effects in a clinical scenario.
Conclusions
In summation, the results of our research can be examined 
in two ways. First, when analyzing in vitro research of the 
isolated LITA rings, one should perhaps take into consid-
eration the fact that during the experiment, the functional 
state of the tissue changes, in particular—its sensitivity 
to cell membrane depolarization. Secondly, the change in 
sensitivity to cell membrane depolarization of the smooth 
muscle LITA cells may be the mechanism influencing the 
post-operative spasm after the CABG surgery.
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